FIELD: medicine, oncology.
SUBSTANCE: in patients before treatment one should detect the content of total 17-oxycorticosteroids, cortisol, cortisone, tetrahydrocortisol, tetrahydrocortisone in daily urine to calculate the ratio for the concentration of total 17-oxycorticosteroids to the sum of cortisol, cortisone, tetrahydrocortisol, tetrahydrocortisone concentrations and at ratio value being below 2.0 (1.1-1.6) it is possible to predict the duration of relapse-free period ranged 3-6 yr after the end of complex therapy, and at ratio value being above 2.0 (2.4-3.2) - the development of relapse for terms up to 1.5 yr after therapy conducted. The method provides accuracy, availability and requires no high financial expenses.
EFFECT: higher accuracy of prediction.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
| METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
| METHOD OF DETERMINING EFFICIENCY OF TREATMENT OF UTERINE BODY CANCER | 2010 |
|
RU2424806C1 |
| METHOD FOR PREDICTION OF CERVICAL CANCER METASTASES | 2010 |
|
RU2436102C1 |
| METHOD OF DETERMINING EFFECIENCY OF LARYNX CANCER TREATMENT | 2008 |
|
RU2375003C1 |
| METHOD FOR PREDICTING VULVA CANCER TREATMENT RESULTS | 1998 |
|
RU2153175C1 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
| METHOD FOR PREDICTING EXTRACRANIAL METASTASES DEVELOPMENT IN PATIENTS HAVING METASTASES IN BRAIN | 2005 |
|
RU2297005C1 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH SEROSAL OVARIAN CANCER | 2005 |
|
RU2299018C1 |
